STOCK TITAN

[Form 4] TALPHERA, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Talphera, Inc. (TLPH) reported a director equity grant on a Form 4. The filing shows 4,267 restricted stock units awarded at $0, and a stock option for 25,600 shares with a $1.14 exercise price. Both the RSUs and the option vest 100% on the one-year anniversary of the 10/23/2025 grant date, subject to continuous service. The option expires on 10/22/2035. Following the transaction, the director beneficially owned 8,547 shares of common stock directly.

Talphera, Inc. (TLPH) ha comunicato una assegnazione di azioni al consiglio mediante una Form 4. La pratica mostra 4.267 unità di azioni vincolate assegnate a $0, e una opzione su 25.600 azioni con prezzo di esercizio di $1,14. Sia le RSU che l'opzione cominciano a maturare al 100% al primo anniversario del grant date del 10/23/2025, subordinatamente al servizio continuo. L'opzione scade il 10/22/2035. A seguito della transazione, il direttore possedeva direttamente 8.547 azioni ordinarie.

Talphera, Inc. (TLPH) informó sobre una adjudicación de acciones para directores en un Form 4. La presentación muestra 4.267 unidades restringidas de acciones otorgadas a $0, y una opción sobre 25.600 acciones con un precio de ejercicio de $1,14. Tanto las RSU como la opción se consolidan al 100% al cumplir un año a partir de la fecha de otorgamiento del 23/10/2025, sujeto a servicio continuo. La opción expira el 22/10/2035. Tras la operación, el director poseía beneficiosamente 8.547 acciones ordinarias directamente.

Talphera, Inc. (TLPH)가 Form 4에서 이사회 보상 주식을 보고했습니다. 제출서는 4,267개의 제한 주식 단위(RSU)$0로 부여되었고, 25,600주에 대한 주식 옵션$1.14의 행사 가격으로 있음을 보여줍니다. RSU와 옵션 모두 10/23/2025의 부여일로부터 1주년100% 비전액으로 취득되며 지속 근무 조건이 적용됩니다. 옵션은 2035년 10월 22일에 만료됩니다. 거래 후 이사는 직접적으로 8,547주의 보통주를 유리하게 소유했습니다.

Talphera, Inc. (TLPH) a communiqué une attribution d’actions au conseil via un Formulaire 4. Le dépôt indique 4 267 unités d’actions restreintes attribuées à $0, et une option d’achat sur 25 600 actions au prix d’exercice de $1,14. Tant les RSU que l’option volentent à 100 % au premier anniversaire de la date d’attribution du 23/10/2025, sous réserve d’un service continu. L’option expire le 22/10/2035. Suite à la transaction, le directeur détenait directement 8 547 actions ordinaires.

Talphera, Inc. (TLPH) hat eine Directors-Eigenkapitalzuteilung in einem Formular 4 gemeldet. Die Einreichung zeigt 4.267 restricted stock units (RSUs) mit einer Zuteilung zu $0 sowie eine Option auf 25.600 Aktien mit einem Ausübungspreis von $1,14. Sowohl die RSUs als auch die Option vest 100 % am einjährigen Jubiläum des Grant-Datums vom 23.10.2025, vorbehaltlich kontinuierlicher Beschäftigung. Die Option läuft am 22.10.2035 ab. Nach der Transaktion hielt der Direktor direkt 8.547 Stammaktien.

Talphera, Inc. (TLPH) ذكرت منحة أسهم للمديرين في النموذج 4. تُظهر الإيداع 4,267 وحدة أسهم مقيدة مُنحت بسعر $0، وخيار أسهم لـ 25,600 سهم بسعر تنفيذ قدره $1.14. كلا من RSUs والخيار يكتملان بنسبة 100% في الذكرى السنوية الأولى لتاريخ المنحة في 23/10/2025، رهناً بالخدمة المستمرة. ينتهي صلاحية الخيار في 22/10/2035. عقب الصفقة، امتلك المدير بشكل مفيد 8,547 سهم عادي بشكل مباشر.

Positive
  • None.
Negative
  • None.

Talphera, Inc. (TLPH) ha comunicato una assegnazione di azioni al consiglio mediante una Form 4. La pratica mostra 4.267 unità di azioni vincolate assegnate a $0, e una opzione su 25.600 azioni con prezzo di esercizio di $1,14. Sia le RSU che l'opzione cominciano a maturare al 100% al primo anniversario del grant date del 10/23/2025, subordinatamente al servizio continuo. L'opzione scade il 10/22/2035. A seguito della transazione, il direttore possedeva direttamente 8.547 azioni ordinarie.

Talphera, Inc. (TLPH) informó sobre una adjudicación de acciones para directores en un Form 4. La presentación muestra 4.267 unidades restringidas de acciones otorgadas a $0, y una opción sobre 25.600 acciones con un precio de ejercicio de $1,14. Tanto las RSU como la opción se consolidan al 100% al cumplir un año a partir de la fecha de otorgamiento del 23/10/2025, sujeto a servicio continuo. La opción expira el 22/10/2035. Tras la operación, el director poseía beneficiosamente 8.547 acciones ordinarias directamente.

Talphera, Inc. (TLPH)가 Form 4에서 이사회 보상 주식을 보고했습니다. 제출서는 4,267개의 제한 주식 단위(RSU)$0로 부여되었고, 25,600주에 대한 주식 옵션$1.14의 행사 가격으로 있음을 보여줍니다. RSU와 옵션 모두 10/23/2025의 부여일로부터 1주년100% 비전액으로 취득되며 지속 근무 조건이 적용됩니다. 옵션은 2035년 10월 22일에 만료됩니다. 거래 후 이사는 직접적으로 8,547주의 보통주를 유리하게 소유했습니다.

Talphera, Inc. (TLPH) a communiqué une attribution d’actions au conseil via un Formulaire 4. Le dépôt indique 4 267 unités d’actions restreintes attribuées à $0, et une option d’achat sur 25 600 actions au prix d’exercice de $1,14. Tant les RSU que l’option volentent à 100 % au premier anniversaire de la date d’attribution du 23/10/2025, sous réserve d’un service continu. L’option expire le 22/10/2035. Suite à la transaction, le directeur détenait directement 8 547 actions ordinaires.

Talphera, Inc. (TLPH) hat eine Directors-Eigenkapitalzuteilung in einem Formular 4 gemeldet. Die Einreichung zeigt 4.267 restricted stock units (RSUs) mit einer Zuteilung zu $0 sowie eine Option auf 25.600 Aktien mit einem Ausübungspreis von $1,14. Sowohl die RSUs als auch die Option vest 100 % am einjährigen Jubiläum des Grant-Datums vom 23.10.2025, vorbehaltlich kontinuierlicher Beschäftigung. Die Option läuft am 22.10.2035 ab. Nach der Transaktion hielt der Direktor direkt 8.547 Stammaktien.

Talphera, Inc. (TLPH) ذكرت منحة أسهم للمديرين في النموذج 4. تُظهر الإيداع 4,267 وحدة أسهم مقيدة مُنحت بسعر $0، وخيار أسهم لـ 25,600 سهم بسعر تنفيذ قدره $1.14. كلا من RSUs والخيار يكتملان بنسبة 100% في الذكرى السنوية الأولى لتاريخ المنحة في 23/10/2025، رهناً بالخدمة المستمرة. ينتهي صلاحية الخيار في 22/10/2035. عقب الصفقة، امتلك المدير بشكل مفيد 8,547 سهم عادي بشكل مباشر.

Talphera, Inc. (TLPH) 在 Form 4 披露了董事股权授予。文件显示 4,267 股受限股票单位,授予价格为 $0,以及一个 25,600 股的股票期权,行权价为 $1.14。RSU 与期权均在 自 2025/10/23 授予日起一周年时100% 的归属完成,前提是持续任职。期权将于 2035/10/22 失效。交易后,董事直接持有 8,547 股普通股。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Broadfoot Jill Marie

(Last) (First) (Middle)
C/O TALPHERA, INC.
1850 GATEWAY DRIVE, SUITE 175

(Street)
SAN MATEO CA 94404

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TALPHERA, INC. [ TLPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/23/2025 A 4,267(2) A $0 8,547 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $1.14 10/23/2025 A 25,600 (3) 10/22/2035 Common Stock 25,600 $0 25,600 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
2. 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
3. 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.
/s/ Martha Adler, Attorney-in-Fact 10/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Talphera Inc

NASDAQ:TLPH

TLPH Rankings

TLPH Latest News

TLPH Latest SEC Filings

TLPH Stock Data

55.08M
32.37M
2.39%
30.1%
2.15%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SAN MATEO